August 17, 2026
BPC-157 vs TB-500: differences, mechanisms, and research use
This article is for research information purposes only. The products mentioned are for laboratory research use only.
[PLACEHOLDER — launch draft; review and expand before publishing]
What is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a protective protein found in human gastric juice. In preclinical models, BPC-157 has been studied for:
- tendon and ligament healing
- protection and repair of the gastrointestinal mucosa
- modulation of signalling pathways involved in angiogenesis
What is TB-500?
TB-500 is the synthetic version of the active fragment (17-23) of thymosin beta-4, a peptide naturally present in nearly all cells. Research has focused on:
- actin regulation and cell motility
- migration of progenitor cells toward injured tissue
- regeneration processes with systemic distribution
Key differences
| Criterion | BPC-157 | TB-500 |
|---|---|---|
| Structure | 15 amino acids | fragment 17-23 of Tβ4 |
| Origin | gastric protein | thymosin beta-4 |
| Studied action | predominantly local | predominantly systemic |
| Literature focus | tendons, GI mucosa | cell migration, regeneration |
Choosing for a research protocol
The choice depends on the study objective: for localized injury models (tendon, ligament, mucosa), preclinical literature has focused on BPC-157; for processes involving systemic cell migration, TB-500 is the more frequently studied peptide. Combined protocols exploit the complementary mechanisms.
Conclusion
BPC-157 and TB-500 are two of the most studied peptides in regeneration research, with distinct but complementary mechanisms. Certificates of analysis (HPLC, mass spectrometry) remain the essential quality criterion when purchasing for the laboratory.
Frequently asked questions
- What is the main difference between BPC-157 and TB-500?
- BPC-157 is a pentadecapeptide derived from a gastric protective protein, studied mostly in models of local tendon and mucosal healing, while TB-500 is the active fragment of thymosin beta-4, a systemically acting peptide studied in the context of cell migration and regeneration.
- Can BPC-157 and TB-500 be studied together?
- In preclinical research literature the two peptides are sometimes investigated in combined protocols because of their complementary mechanisms — local versus systemic. Both are strictly for laboratory research use.
- How should these peptides be stored?
- Lyophilized, both are stored at -20°C protected from light. After reconstitution with bacteriostatic water, store at 2–8°C and use generally within 30 days.